Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 — Fargo, North Dakota

Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 is a clinical research site located in Fargo, North Dakota, United States 58122.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058?

Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 conducted?

Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 accredited by Crixeo Health?

Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sanford Roger Maris Cancer Center - Fargo 801 Broadway North Route 1058?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.